Biallelic TET2 mutations confer sensitivity to 5'-azacitidine in acute myeloid leukemia.

MLA

Stölzel, Friedrich, et al. “Biallelic TET2 Mutations Confer Sensitivity to 5’-Azacitidine in Acute Myeloid Leukemia.” JCI Insight, 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1391581933&authtype=sso&custid=ns315887.

APA

Stölzel, F., Stölzel, F., Fordham, S. E., Nandana, D., Lin, W.-Y., Blair, H., Elstob, C., Bell, H. L., Mohr, B., Ruhnke, L., Kunadt, D., Dill, C., Allsop, D., Piddock, R., Soura, E.-N., Park, C., Fadly, M., Rahman, T., Alharbi, A., … Allan, J. M. (2023). Biallelic TET2 mutations confer sensitivity to 5’-azacitidine in acute myeloid leukemia. JCI Insight.

Chicago

Stölzel, Friedrich, Friedrich Stölzel, Sarah E Fordham, Devi Nandana, Wei-Yu Lin, Helen Blair, Claire Elstob, et al. 2023. “Biallelic TET2 Mutations Confer Sensitivity to 5’-Azacitidine in Acute Myeloid Leukemia.” JCI Insight. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1391581933&authtype=sso&custid=ns315887.